Fundz

Dr. Raolat Abdulai Appointed as Chief Medical Officer at Galvani Bioelectronics

PRIVATEJul 17, 2024

Position

Chief Medical Officer

Company

Galvani Bioelectronics

Raolat Abdulai
BiotechnologyHealth CareMedical

Description

Galvani Bioelectronics is recruiting for a randomized, controlled stage of a clinical feasibility study for patients with Rheumatoid Arthritis (RA) and has received approval from the US Food and Drug Administration (FDA) for this progression. Dr. Raolat Abdulai is joining the company as Chief Medical Officer in August.

Quick answer

Dr. Raolat Abdulai Appointed as Chief Medical Officer at Galvani Bioelectronics (July 17, 2024).

Who is the new Chief Medical Officer at Galvani Bioelectronics?
Galvani Bioelectronics named Raolat Abdulai Chief Medical Officer, announced July 17, 2024.
What did Galvani Bioelectronics announce on July 17, 2024?
Galvani Bioelectronics is recruiting for a randomized, controlled stage of a clinical feasibility study for patients with Rheumatoid Arthritis (RA) and has received approval from the US Food and Drug Administration (FDA) for this progression. Dr. Raolat Abdulai is joining the company as Chief Medical Officer in August.
What does Galvani Bioelectronics do?
Galvani Bioelectronics is a pioneering research and development company dedicated to bringing bioelectronic therapies to patients.
Which similar companies made leadership changes around the same time?
Versiti (July 23, 2024), Eli Lilly and Company (July 10, 2024), American Osteopathic Association (July 25, 2024) and NYU Langone Health (July 25, 2024) also announced leadership changes within 45 days of Galvani Bioelectronics.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Galvani Bioelectronics, and when

A new leader at Galvani Bioelectronics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Galvani Bioelectronics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Galvani Bioelectronics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Galvani Bioelectronics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Galvani Bioelectronics

About

Galvani Bioelectronics is a pioneering research and development company dedicated to bringing bioelectronic therapies to patients. The company was formed through a partnership between two global healthcare companies, GSK and Verily Life Sciences, a subsidiary of Alphabet Inc. Galvani is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Galvani Bioelectronics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Galvani Bioelectronics's next move

Learn about Strategic plan

Galvani Bioelectronics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.